| Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood S Weihrauch-Blüher, P Schwarz, JH Klusmann Metabolism 92, 147-152, 2019 | 533 | 2019 |
| lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling Y Lu, X Zhao, Q Liu, C Li, R Graves-Deal, Z Cao, B Singh, JL Franklin, ... Nature medicine 23 (11), 1331-1341, 2017 | 375 | 2017 |
| Next-generation personalised medicine for high-risk paediatric cancer patients–The INFORM pilot study BC Worst, CM van Tilburg, GP Balasubramanian, P Fiesel, R Witt, ... European journal of cancer 65, 91-101, 2016 | 326 | 2016 |
| Developmental stage–selective effect of somatically mutated leukemogenic transcription factor GATA1 Z Li, FJ Godinho, JH Klusmann, M Garriga-Canut, C Yu, SH Orkin Nature genetics 37 (6), 613-619, 2005 | 318 | 2005 |
| Treatment and prognostic impact of transient leukemia in neonates with Down syndrome JH Klusmann, U Creutzig, M Zimmermann, M Dworzak, N Jorch, ... Blood, The Journal of the American Society of Hematology 111 (6), 2991-2998, 2008 | 297 | 2008 |
| Refined sgRNA efficacy prediction improves large-and small-scale CRISPR–Cas9 applications M Labuhn, FF Adams, M Ng, S Knoess, A Schambach, EM Charpentier, ... Nucleic acids research 46 (3), 1375-1385, 2018 | 273 | 2018 |
| miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia JH Klusmann, Z Li, K Böhmer, A Maroz, ML Koch, S Emmrich, FJ Godinho, ... Genes & development 24 (5), 478-490, 2010 | 264 | 2010 |
| Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 M Rasche, M Zimmermann, L Borschel, JP Bourquin, M Dworzak, ... Leukemia 32 (10), 2167-2177, 2018 | 224 | 2018 |
| miR-99a/100∼ 125b tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGFβ and Wnt signaling S Emmrich, M Rasche, J Schöning, C Reimer, S Keihani, A Maroz, Y Xie, ... Genes & development 28 (8), 858-874, 2014 | 194 | 2014 |
| LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia S Emmrich, A Streltsov, F Schmidt, VR Thangapandi, D Reinhardt, ... Molecular cancer 13, 1-12, 2014 | 163 | 2014 |
| The non-coding RNA landscape of human hematopoiesis and leukemia A Schwarzer, S Emmrich, F Schmidt, D Beck, M Ng, C Reimer, FF Adams, ... Nature communications 8 (1), 1-17, 2017 | 159 | 2017 |
| The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets CM Van Tilburg, E Pfaff, KW Pajtler, KPS Langenberg, P Fiesel, BC Jones, ... Cancer discovery 11 (11), 2764-2779, 2021 | 158 | 2021 |
| Next‐generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3‐ITD or NPM1 mutations F Thol, B Kölking, F Damm, K Reinhardt, JH Klusmann, D Reinhardt, ... Genes, Chromosomes and Cancer 51 (7), 689-695, 2012 | 155 | 2012 |
| Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis JH Klusmann, FJ Godinho, K Heitmann, A Maroz, ML Koch, D Reinhardt, ... Genes & development 24 (15), 1659-1672, 2010 | 148 | 2010 |
| Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome M Labuhn, K Perkins, S Matzk, L Varghese, C Garnett, E Papaemmanuil, ... Cancer cell 36 (2), 123-138. e10, 2019 | 135 | 2019 |
| Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy MV Stankov, M El Khatib, B Kumar Thakur, K Heitmann, ... Leukemia 28 (3), 577-588, 2014 | 130 | 2014 |
| Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia KA Alford, K Reinhardt, C Garnett, A Norton, K Böhmer, C von Neuhoff, ... Blood, The Journal of the American Society of Hematology 118 (8), 2222-2238, 2011 | 129 | 2011 |
| The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells L Dan, O Klimenkova, M Klimiankou, JH Klusman, ... Haematologica 97 (4), 551, 2012 | 123 | 2012 |
| Lost in translation: pluripotent stem cell‐derived hematopoiesis M Ackermann, S Liebhaber, JH Klusmann, N Lachmann EMBO molecular medicine 7 (11), 1388-1402, 2015 | 101 | 2015 |
| The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study JH Klusmann, D Reinhardt, M Zimmermann, B Kremens, J Vormoor, ... Haematologica 97 (1), 21, 2012 | 101 | 2012 |
Dirk ReinhardtUniversity Hospital EssenDirección de correo verificada de uk-essen.de
